Five Health Conditions Linked to Subsequent Diagnosis of MS

Follow Drugslib on

Medically reviewed by Carmen Pope, BPharm. Last updated on Dec 5, 2023.

By Elana Gotkine HealthDay Reporter

TUESDAY, Dec. 5, 2023 -- Five health conditions are associated with subsequent diagnosis of multiple sclerosis, but they overlap with two other autoimmune diseases, according to a study published online Dec. 5 in Neurology.

Octave Guinebretiere, from Sorbonne Université in Paris, and colleagues examined the association between diseases and symptoms diagnosed in primary care and the risk for MS relative to controls and two other autoimmune inflammatory diseases (lupus and Crohn disease) in a case-control study. The study population included 20,174 patients with MS; 54,790 patients without MS; 30,477 patients with Crohn disease; and 7,337 patients with lupus.

The researchers observed significant positive associations for 12 International Classification of Diseases, 10th Revision (ICD-10) codes with the risk for MS compared with controls without MS. Five codes remained significantly associated with MS after considering ICD-10 codes suggestive of neurological symptoms as the first diagnosis of MS: depression, sexual dysfunction, constipation, cystitis, and urinary tract infections of unspecified site (odds ratios, 1.22, 1.47, 1.50, 1.21, and 1.38, respectively). In comparisons with lupus and Crohn disease, none of these conditions was selectively associated with MS. During the five years after diagnosis, all five ICD-10 codes identified were still associated with MS.

"Due to the frequency of these symptoms in the general population and the nonspecificity regarding prodrome in other autoimmune diseases, we should not expect that the identification of a prodrome will dramatically change clinical care, at least in the general population," the authors write.

Several authors disclosed ties to the pharmaceutical industry.

Abstract/Full Text (subscription or payment may be required)

Editorial (subscription or payment may be required)

Disclaimer: Statistical data in medical articles provide general trends and do not pertain to individuals. Individual factors can vary greatly. Always seek personalized medical advice for individual healthcare decisions.

Source: HealthDay

Posted : 2023-12-06 08:37

Read more

Disclaimer

Every effort has been made to ensure that the information provided by Drugslib.com is accurate, up-to-date, and complete, but no guarantee is made to that effect. Drug information contained herein may be time sensitive. Drugslib.com information has been compiled for use by healthcare practitioners and consumers in the United States and therefore Drugslib.com does not warrant that uses outside of the United States are appropriate, unless specifically indicated otherwise. Drugslib.com's drug information does not endorse drugs, diagnose patients or recommend therapy. Drugslib.com's drug information is an informational resource designed to assist licensed healthcare practitioners in caring for their patients and/or to serve consumers viewing this service as a supplement to, and not a substitute for, the expertise, skill, knowledge and judgment of healthcare practitioners.

The absence of a warning for a given drug or drug combination in no way should be construed to indicate that the drug or drug combination is safe, effective or appropriate for any given patient. Drugslib.com does not assume any responsibility for any aspect of healthcare administered with the aid of information Drugslib.com provides. The information contained herein is not intended to cover all possible uses, directions, precautions, warnings, drug interactions, allergic reactions, or adverse effects. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.

Popular Keywords